Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › NMR analyzers for clinical evaluation of biosamples

NMR analyzers for clinical evaluation of biosamples

US Patent 8704521 · Granted Apr 22, 2014

Estimated economic value: $615,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NMR system and methods for multi-parameter metabolic vulnerability index evaluat2024
Cardiovascular risk evaluations using a risk parameter that includes an HDL and 2024
Multiple-marker risk parameters predictive of conversion to diabetes2024
Methods, systems and computer programs for assessing CHD risk using adjusted HDL2024
NMR quantification of TMAO2023
NMR quantification of TMAO2023
NMR quantification of TMAO2023
Multi-parameter diabetes risk evaluations2023
CHD risk stratification evaluations for subjects with high levels of large HDL-P2023
NMR measurements of NMR biomarker GlycA2023
Methods and systems to detect and quantify the amount of LP-X and other abnormal2022
Cardiovascular risk evaluations using a risk parameter that includes an HDL and 2022